MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0001563
Daxin Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹93.78 Cr
▲ 40% YoY
Net profit · FY 2025
₹2.43 Cr
Net margin 2.6%
EBITDA · FY 2025
₹5.33 Cr
EBITDA margin 5.7%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.84 Cr
Issued & subscribed
Open charges
₹30.55 Cr
Satisfied ₹1.95 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
78
Provident fund records
About Daxin Pharmaceuticals Private Limited
Data last updated:
Daxin Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC264559. Its GSTIN is 10AAECD9603K1ZU (Bihar). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.84 Cr. It is led by directors Sheela Jha and Nikhil Kumar Jha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No – 204 205 2nd Floor, Apra Dwarka Plaza – I Plot No – 21 Sector – 10 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹93.78 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹2.43 Cr (net margin 2.6%) and EBITDA of ₹5.33 Cr (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 58% over three years and 56% over five years.
The company has about 78 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Daxin Pharma. As per MCA filings, the company has open charges of ₹30.55 Cr and satisfied charges of ₹1.95 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 5 cases are pending.
Daxin Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0001563). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daxinpharma.in.
Company details
CIN U24100DL2014PTC264559
Registration Number 264559
Incorporation Date 06 February 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0001563
Key People
Sheela Jha Director Nikhil Kumar Jha Director Recognitions & Rankings of Daxin Pharmaceuticals
Contact details
Daxin Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is daxinpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No – 204 205 2nd Floor, Apra Dwarka Plaza – I Plot No – 21 Sector – 10 Dwarka, New Delhi, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Daxin Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Daxin Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Daxin Pharmaceuticals operates one associated brand: Daxin Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces pharmaceutical tablets, capsules, liquids, and injections for worldwide healthcare markets. | daxinpharma.in |
Business activity
The main business activities of Daxin Pharmaceuticals are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Daxin Pharmaceuticals Private Limited, buy the company report.
Financials of Daxin Pharmaceuticals Private Limited
FY 2024 filings availableDaxin Pharmaceuticals Private Limited reported revenue of ₹93.78 Cr (up 40% YoY) for FY 2025.
Revenue · FY 2025
₹93.78 Cr ▲ 40%
Net profit · FY 2025
₹2.43 Cr margin 2.6%
EBITDA · FY 2025
₹5.33 Cr margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 58%
5 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 42%
5 years · compounded
▲ 40%
Revenue has grown at a compounded annual rate (CAGR) of 56% over five years, including 40% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daxin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Daxin Pharmaceuticals Private Limited
Daxin Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sheela Jha | Director | 06 Feb 2014 | 12 Years 8 Months | Current |
| Nikhil Kumar Jha | Director | 16 Feb 2014 | 12 Years 8 Months | Current |
Auditor
Daxin Pharmaceuticals Private Limited is audited by KAUSHAL ANKITA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAUSHAL ANKITA & ASSOCIATES | FY 2024 | 022772C |
Shareholding
The shareholding of Daxin Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Daxin Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30.55 Cr
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2024 | 100913441 | Others | ₹32.97 Lakh | Open | |
| 25 Nov 2021 | 100504861 | Others | ₹1.05 Cr | Open | |
| 20 Nov 2020 | 100402828 | Others | ₹29.17 Cr | Open | |
| 30 May 2015 | 10578019 | Others | ₹1.95 Cr | Satisfied |
To see the full charge records of Daxin Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Daxin Pharmaceuticals Private Limited has 6 court cases on record: 2 filed by Daxin Pharmaceuticals, 4 filed against it. 5 cases are pending and 1 is disposed.
Total cases
6
Filed by the company
2
Filed against the company
4
Pending
5
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 4 | 5 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Khushi Jain Proprietor of Daxin Pharmaceutical Bangalore | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed by the company against M/S Suncure Pharmaceuticals Pvt Ltd and 1 other | Pending |
| District court, Solan, Himachal Pradesh | Court case (Workman's Compensation Act) | Filed against the company by an individual | Pending |
| District court, Nizamabad, Telangana | Criminal complaint | Filed against the company by State of Telangana Drugs Insepctor, Nizamabad District. | Pending |
| District court, Yadadri Bhuvanagiri, Telangana | Criminal complaint | Filed against the company by State of Telangana Rep by Drugs Inspector, Yadadri Bhuvnagiri District | Pending |
To see the full case history of Daxin Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daxin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Daxin Pharmaceuticals Private Limited has a workforce of 78 employees on its EPFO records as of Mar 24, 2025, across 2 active EPFO establishments.
Employee count
78
Active EPFO establishments
2
Employee growth
-43.07%
GST
Daxin Pharmaceuticals has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECD9603K1ZU | Bihar | Active | 01 Jul 2017 |
| 02AAECD9603K1ZR | Himachal Pradesh | Active | 12 Oct 2020 |
| 02AAECD9603K2ZQ | Himachal Pradesh | Active | 02 Jul 2024 |
| 06AAECD9603K1ZJ | Haryana | Active | 22 Oct 2024 |
To see the full GST registrations and return filing status of Daxin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Daxin Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Anand Kumar Jha ceased to be Director on 16 Feb 2014.
Charges
A charge with Others of Rs. 29.17 Cr registered on 20 Nov 2020 with Charge ID 100402828 was modified on 03 Jun 2025.
AGM
Daxin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100913441 was registered on 20 Apr 2024.
Filing
Daxin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 30 May 2015 via Charge ID 10578019 with Others was fully satisfied on 04 Jan 2024.
Charges
A charge with Others amounted to Rs. 1.05 Cr with Charge ID 100504861 was registered on 25 Nov 2021.
Charges
A charge with Others amounted to Rs. 29.17 Cr with Charge ID 100402828 was registered on 20 Nov 2020.
Charges
A charge with Others of Rs. 1.95 Cr registered on 30 May 2015 with Charge ID 10578019 was modified on 21 Jun 2016.
Charges
A charge with Others amounted to Rs. 1.95 Cr with Charge ID 10578019 was registered on 30 May 2015.
Ceased
Anand Kumar Jha ceased to be Director.
Appointed
Nikhil Kumar Jha was appointed as Director.
Appointed
Sheela Jha was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Daxin Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 February 2014 (12+ years old) and is registered under CIN U24100DL2014PTC264559.
Daxin Pharmaceuticals has 2 current directors:
- Sheela Jha - Director
- Nikhil Kumar Jha - Director
The latest financial statements of Daxin Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Daxin Pharmaceuticals is 10AAECD9603K1ZU, registered in Bihar. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 02AAECD9603K1ZR (Himachal Pradesh), 02AAECD9603K2ZQ (Himachal Pradesh), 06AAECD9603K1ZJ (Haryana).
The CIN (Corporate Identification Number) of Daxin Pharmaceuticals is U24100DL2014PTC264559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daxin Pharmaceuticals has 6 court cases on record: 2 filed by the company and 4 filed against it. 5 are pending.
Daxin Pharmaceuticals was incorporated on 06 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Anand Kumar Jha ceased to be Director on 16 Feb 2014. Nikhil Kumar Jha was appointed as Director on 16 Feb 2014. Sheela Jha was appointed as Director on 06 Feb 2014.
Yes, Daxin Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0001563).
Daxin Pharmaceuticals can be reached through the website daxinpharma.in. Its registered office is in New Delhi, Delhi, India.